Ferroptosis regulation by methylation in cancer.
暂无分享,去创建一个
[1] Liucun Zhu,et al. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma , 2022, International journal of molecular sciences.
[2] Jinglin Mi,et al. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis , 2022, Translational oncology.
[3] W. Xue,et al. USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia–reperfusion injury , 2022, Inflammation Research.
[4] Qingzhi Guo,et al. Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma , 2022, Frontiers in Immunology.
[5] Haihua Yang,et al. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma , 2022, Journal of oncology.
[6] Jia Peng,et al. KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion. , 2022, Journal of molecular and cellular cardiology.
[7] Hongjun Xie,et al. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma , 2022, Frontiers in Immunology.
[8] B. Henkelmann,et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor , 2022, Nature.
[9] B. Stockwell. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications , 2022, Cell.
[10] Yuanbin Chen,et al. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma , 2022, Oncogene.
[11] Juan Chen,et al. GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis , 2022, Frontiers in Cardiovascular Medicine.
[12] C. Zhuang,et al. The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma , 2022, Clinical and translational medicine.
[13] Kellen L. Olszewski,et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers , 2022, Nature Communications.
[14] Yuting He,et al. Alveolar macrophage-derived exosomal tRF-22-8BWS7K092 activates Hippo signaling pathway to induce ferroptosis in acute lung injury. , 2022, International immunopharmacology.
[15] Chun Fu,et al. Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells , 2022, Stem cells international.
[16] Feng Zhang,et al. m6A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. , 2022, Free radical biology & medicine.
[17] Jiayi Wang,et al. Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma , 2022, Cancer communications.
[18] Jianglin Wang,et al. Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer. , 2022, Free radical biology & medicine.
[19] Yiming Xu,et al. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification , 2022, Cancer cell international.
[20] Jiansheng Li,et al. Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway. , 2021, Archives of biochemistry and biophysics.
[21] B. Pang,et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner , 2022, Cell death & disease.
[22] G. Gkoutos,et al. IRON-MEDIATED EPIGENETIC ACTIVATION OF NRF2 TARGETS. , 2021, The Journal of nutritional biochemistry.
[23] Shujun Liu,et al. Gold Nanorods Exhibit Intrinsic Therapeutic Activity via Controlling N6-Methyladenosine-Based Epitranscriptomics in Acute Myeloid Leukemia. , 2021, ACS nano.
[24] M. Shu,et al. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11 , 2021, Journal of cellular and molecular medicine.
[25] M. Weng,et al. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer , 2021, Journal of advanced research.
[26] Feng Zhang,et al. N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells , 2021, Redox biology.
[27] Hui Wang,et al. Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications , 2021, Frontiers in Oncology.
[28] Zhifu Sun,et al. A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma , 2021, Journal of cellular and molecular medicine.
[29] Yuan Guo,et al. Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells , 2021, Cell death discovery.
[30] Xiaofeng Dai,et al. Methylation multiplicity and its clinical values in cancer , 2021, Expert Reviews in Molecular Medicine.
[31] Y. Tao,et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] Gang Jia,et al. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. , 2021, Life sciences.
[33] Quan Zhang,et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells , 2021, Journal of Hematology & Oncology.
[34] Li Li,et al. The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease , 2021, Cell death & disease.
[35] Y. Huh,et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. , 2020, Proceedings of the National Academy of Sciences of the United States of America.
[36] T. Tong,et al. CRL4DCAF8 dependent opposing stability control over the chromatin remodeler LSH orchestrates epigenetic dynamics in ferroptosis , 2020, Cell Death & Differentiation.
[37] X. Zhang,et al. The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function , 2020, Redox biology.
[38] Zhiying Ai,et al. Discovery of a novel ferroptosis inducer-talaroconvolutin A—killing colorectal cancer cells in vitro and in vivo , 2020, Cell Death & Disease.
[39] Amit Kumar,et al. Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases , 2020, Neurobiology of Disease.
[40] Yanzhang Li,et al. Corrigendum to “IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer” , 2020, Oxidative medicine and cellular longevity.
[41] T. Efferth,et al. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[42] W. Xue,et al. SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis , 2020, Acta pharmaceutica Sinica. B.
[43] Bao Huang,et al. Homocysteine Induces Oxidative Stress and Ferroptosis of Nucleus Pulposus Via Enhancing Methylation of GPX4. , 2020, Free radical biology & medicine.
[44] P. Singh,et al. A Novel Redox Modulator Induces a GPX4-mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species. , 2020, Journal of medicinal chemistry.
[45] Y. Zhong,et al. FTY720 induces ferroptosis and autophagy via PP2A/AMPK pathway in multiple myeloma cells. , 2020, Life sciences.
[46] B. Stockwell,et al. Emerging Mechanisms and Disease Relevance of Ferroptosis. , 2020, Trends in cell biology.
[47] D. Tang,et al. Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death , 2020, Cancer Gene Therapy.
[48] I. Yanatori,et al. Ferroptosis at the crossroads of infection, aging and cancer , 2020, Cancer science.
[49] Shouping Xu,et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin , 2020, Journal of cellular physiology.
[50] P. Clemons,et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles , 2020, Nature Chemical Biology.
[51] Zhen Zou,et al. Arsenite induces testicular oxidative stress in vivo and in vitro leading to ferroptosis. , 2020, Ecotoxicology and environmental safety.
[52] Min Yu,et al. Characteristics of iron status, oxidation response, and DNA methylation profile in response to occupational iron oxide nanoparticles exposure , 2020, Toxicology and industrial health.
[53] Chengliang Zhang,et al. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11 , 2020, FEBS open bio.
[54] Xiaohong Wang,et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC , 2020, Molecular Cancer.
[55] Y. Liu,et al. Expression and prognostic potential of GPX1 in human cancers based on data mining. , 2020, Annals of translational medicine.
[56] S. Mou,et al. The N6‐methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1 , 2020, Journal of cellular biochemistry.
[57] C. Thompson,et al. Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation. , 2019, Cell metabolism.
[58] Edward W. Tate,et al. FSP1 is a glutathione-independent ferroptosis suppressor , 2019, Nature.
[59] J. Olzmann,et al. The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.
[60] D. Hsu,et al. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. , 2019, Cell reports.
[61] B. Stockwell,et al. A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System. , 2019, Cell metabolism.
[62] B. Stockwell,et al. Intercellular interaction dictates cancer cell ferroptosis via Merlin-YAP signalling , 2019, Nature.
[63] D. Krysko,et al. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion , 2019, Nature Reviews Cancer.
[64] K. Guan,et al. The Hippo Pathway: Biology and Pathophysiology. , 2019, Annual review of biochemistry.
[65] W. Cui,et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53 , 2019, EMBO reports.
[66] B. Stockwell,et al. Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. , 2019, Cell chemical biology.
[67] D. Pang,et al. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells , 2019, Cell Death & Disease.
[68] M. Jackson,et al. Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells , 2019, Scientific Reports.
[69] A. Chinnaiyan,et al. CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy , 2019, Nature.
[70] W. Gu,et al. ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway , 2019, Nature Cell Biology.
[71] P. Vandenabeele,et al. The molecular machinery of regulated cell death , 2019, Cell Research.
[72] B. Gan,et al. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1 , 2019, Cell cycle.
[73] Na Liu,et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA , 2019, Cell Death & Differentiation.
[74] Junying Yuan,et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis , 2019, Proceedings of the National Academy of Sciences.
[75] W. Fan,et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin , 2019, Free radical biology & medicine.
[76] F. Gao,et al. Ferroptosis as a target for protection against cardiomyopathy , 2019, Proceedings of the National Academy of Sciences.
[77] Yunyan Gu,et al. RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome , 2019, Database J. Biol. Databases Curation.
[78] Yi Chen,et al. Iron Metabolism in Cancer , 2018, International journal of molecular sciences.
[79] Yang Liu,et al. Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway. , 2018, European journal of medicinal chemistry.
[80] Wei Li,et al. BAP1 links metabolic regulation of ferroptosis to tumor suppression , 2018, Nature Cell Biology.
[81] Lianhua Liu,et al. Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer , 2018, BioMetals.
[82] P. Shang,et al. Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer , 2018, International journal of molecular sciences.
[83] G. Ateş,et al. Oxytosis/Ferroptosis—(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System , 2018, Front. Neurosci..
[84] B. Stockwell,et al. FINO2 Initiates Ferroptosis Through GPX4 Inactivation and Iron Oxidation , 2018, Nature Chemical Biology.
[85] J. Lemasters,et al. Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells☆ , 2018, Biochemical pharmacology.
[86] S. Lipton,et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.
[87] A. Sfera,et al. Ferrosenescence: The iron age of neurodegeneration? , 2017, Mechanisms of Ageing and Development.
[88] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[89] Xiaojiang Li,et al. The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis. , 2017, Cellular signalling.
[90] C. Philpott,et al. Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells. , 2017, Blood cells, molecules & diseases.
[91] G. Kroemer,et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. , 2017, Cell reports.
[92] Y. Tao,et al. EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes , 2017, Theranostics.
[93] Jill P. Mesirov,et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway , 2017, Nature.
[94] S. Lowe,et al. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function , 2017, Molecular cell.
[95] S. Giulitti,et al. YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate , 2017, Nature Communications.
[96] D. Birnbaum,et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes , 2017, Nature Chemistry.
[97] Zhenyu Li,et al. Ferroptosis: A Novel Anti-tumor Action for Cisplatin , 2017, Cancer research and treatment : official journal of Korean Cancer Association.
[98] L. Schöckel,et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells , 2017, Cell Death and Disease.
[99] S. Rivella,et al. Targeting iron metabolism in drug discovery and delivery , 2017, Nature Reviews Drug Discovery.
[100] A. Suzuki,et al. Targeting the Hippo signalling pathway for cancer treatment. , 2016, Journal of biochemistry.
[101] J. Roh,et al. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis , 2016, Redox biology.
[102] V. Ellenrieder,et al. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon? , 2016, Gut.
[103] B. Stockwell,et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis , 2016, Proceedings of the National Academy of Sciences.
[104] D. Tang,et al. Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis , 2016, Hepatology.
[105] B. Stockwell,et al. Global Survey of Cell Death Mechanisms Reveals Metabolic Regulation of Ferroptosis , 2016, Nature chemical biology.
[106] L. Yin,et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells , 2016, Oncotarget.
[107] L. Saso,et al. Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants , 2016, Oxidative medicine and cellular longevity.
[108] D. Tang,et al. Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.
[109] Xiaozhou He,et al. Decreased expression of ferroportin in prostate cancer. , 2015, Oncology letters.
[110] F. Zhan,et al. Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation. , 2015, Cancer research.
[111] J. Mandl,et al. Ferroptosis is Involved in Acetaminophen Induced Cell Death , 2015, Pathology & Oncology Research.
[112] Nils Eling,et al. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells , 2015, Oncoscience.
[113] T. Vellai,et al. The mechanism of ageing: primary role of transposable elements in genome disintegration , 2015, Cellular and Molecular Life Sciences.
[114] W. Gu,et al. Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.
[115] Caiguo Zhang,et al. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities , 2014, Protein & Cell.
[116] B. Chauffert,et al. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. , 2014, Anticancer research.
[117] D. Buzas,et al. Epigenetic role for the conserved Fe-S cluster biogenesis protein AtDRE2 in Arabidopsis thaliana , 2014, Proceedings of the National Academy of Sciences.
[118] Jonathan A. Cooper,et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. , 2014, Cancer cell.
[119] Frans van Roy,et al. Beyond E-cadherin: roles of other cadherin superfamily members in cancer , 2014, Nature Reviews Cancer.
[120] Matthew E. Welsch,et al. Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.
[121] I. Pogribny,et al. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents. , 2013, International journal of oncology.
[122] M. Dawson,et al. Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.
[123] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[124] P. Mandal,et al. Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity. , 2010, Neoplasia.
[125] Paolo Sassone-Corsi,et al. Decoding the Epigenetic Language of Neuronal Plasticity , 2008, Neuron.
[126] N. Plesnila,et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. , 2008, Cell metabolism.
[127] V. Skiada,et al. Redox signaling and cancer: the role of "labile" iron. , 2008, Cancer letters.
[128] B. Stockwell,et al. RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels , 2007, Nature.
[129] Gustavo Helguera,et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.
[130] G. Berx,et al. Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.
[131] P. Maher,et al. Oxytosis: A novel form of programmed cell death. , 2001, Current topics in medicinal chemistry.
[132] D. Piani,et al. Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. , 1994, Journal of immunology.
[133] T. Murphy,et al. Calcium-dependent glutamate cytotoxicity in a neuronal cell line , 1988, Brain Research.
[134] K. Piez,et al. The biosynthesis of cystine in human cell cultures. , 1961, The Journal of biological chemistry.
[135] F. De Ritis,et al. [Enzymatic mechanisms of transsulfuration in biology and clinical practice]. , 1956, Giornale di clinica medica.
[136] H. Eagle,et al. Nutrition needs of mammalian cells in tissue culture. , 1955, Science.
[137] OUP accepted manuscript , 2022, Rheumatology.
[138] A. Walch,et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.
[139] H. Kasai,et al. DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications. , 2010, Bioorganic & medicinal chemistry letters.
[140] Matthias W. Hentze,et al. Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.